Nidymo (Melatonin)

Nidymo, a melatonin receptor agonist, acts on the circadian rhythm pathway to improve sleep quality.

• Insomnia: promotes sleep initiation and maintenance in individuals with difficulty staying asleep.
• Sleep onset difficulties: reduces the time required to fall asleep in patients with delayed sleep phase.
• Jet lag: helps realign the internal clock after rapid trans‑meridian travel, easing daytime fatigue.

• Melatonin binds to MT1 and MT2 receptors in the suprachiasmatic nucleus, mimicking the endogenous hormone. Activation of these G‑protein‑coupled receptors modulates circadian signaling, leading to a reduction in neuronal firing that promotes sleep onset and helps synchronize the body's internal clock with the external light‑dark cycle.

Nidymo may cause a range of adverse reactions.

Common Side Effects

• Headache: mild to moderate discomfort often occurring after the first dose.
• Dizziness: transient light‑headedness, especially when standing quickly.
• Daytime sleepiness: residual drowsiness if taken too late.
• Nausea: mild stomach upset after ingestion.
• Vivid dreams: unusual or intense dreaming patterns.
• Mild gastrointestinal discomfort: occasional abdominal cramping.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling of face or throat.
• Depression or mood changes: worsening of depressive symptoms in susceptible individuals.
• Severe hypotension: marked drop in blood pressure leading to faintness.
• Hallucinations: rare visual or auditory disturbances.
• Suicidal thoughts: emergent in patients with underlying psychiatric conditions.

Before using Nidymo, consider the following safety measures.

• Assess underlying conditions: evaluate for depression, seizure disorders, or severe hepatic impairment.
• Avoid alcohol: concurrent consumption may increase sedation.
• Pregnancy: consult a healthcare professional before use.
• Elderly patients: start with the lowest effective dose due to increased sensitivity.
• Review concomitant medications: check for potential drug interactions.
• Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and light.

Melatonin can interact with several medicines; monitoring is advised.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): may increase bleeding risk.
• Immunosuppressants (e.g., cyclosporine): may reduce melatonin efficacy.
• Central nervous system depressants (e.g., benzodiazepines): additive sedation.

Moderate Interactions (Monitor Closely)

• Antidepressants (e.g., SSRIs): may alter melatonin metabolism.
• Oral contraceptives: can raise plasma melatonin concentrations.
• Beta‑blockers: may blunt endogenous melatonin production.